https://pubmed.ncbi.nlm.nih.gov/18286536/
The gemcitabine and vinorelbine combination was moderately active and had an acceptable toxicity profile in pemetrexed-pretreated patients with MPM. The role...
gemcitabinevinorelbinepemetrexedpatientsmalignant